Links
[1] https://www.msh.org/resources/community-based-dots-for-improved-tb-case-detection-and-treatment-outcomes-in-afghanistan?page=42
[2] https://www.msh.org/resources/community-based-dots-for-improved-tb-case-detection-and-treatment-outcomes-in-afghanistan
[3] https://www.msh.org/resources/health-systems-strengthening-and-tb-a-guide-to-msh-events-at-the-2019-union-world?page=42
[4] https://www.msh.org/resources/%E2%80%8B%E2%80%8B%E2%80%8Bresponse-to-anti-tuberculosis-treatment-by-people-over-age-60-in-kampala-uganda?page=42
[5] https://www.msh.org/resources/knowledge-attitudes-and-practices-related-to-tb-among-the-general-population-of-ethiopia?page=42
[6] https://www.msh.org/resources/request-for-proposals-trainings-for-health-technology-assessment-implementers-and-users?page=42
[7] https://www.msh.org/resources/understanding-job-satisfaction-and-motivation-among-nurses-in-public-health-facilities-of?page=42
[8] https://www.msh.org/resources/integrating-pharmacokinetics-and-pharmacodynamics-in-operational-research-to-end-tb?page=42
[9] https://www.msh.org/resources/uptake-and-correlates-of-hiv-testing-among-men-in-malawi-evidence-from-a-national-0?page=42
[10] https://www.msh.org/resources/landscape-analysis-of-verification-and-serialization-system-in-ukraine?page=42
[11] https://www.msh.org/resources/landscape-analysis-of-verification-and-serialization-system-in-ukraine
[12] https://www.msh.org/resources/safemed-activity-news-digest-october-2019?page=42
[13] https://www.msh.org/resources/safemed-activity-news-digest-october-2019
[14] https://www.msh.org/resources/introducing-a-new-strategy-on-bioequivalence-in-ukraine?page=42
[15] https://www.msh.org/resources/introducing-a-new-strategy-on-bioequivalence-in-ukraine
[16] https://www.msh.org/resources/landscape-review-private-logistics-and-distribution-of-medicinal-products-in-ukraine?page=42
[17] https://www.msh.org/resources/appel-%C3%A0-propositions-ihsa-2019-002?page=42
[18] https://www.msh.org/resources/annexe-a-mod%C3%A8le-de-narratif-de-budget?page=42
[19] https://www.msh.org/resources/annexe-b-modele-de-budget?page=42
[20] https://www.msh.org/resources/appel-%C3%A0-propositions-r%C3%A9alisation-d%E2%80%99une-enqu%C3%AAte-de-couverture-d%E2%80%99une-campagne-de-chimio?page=42
[21] https://www.msh.org/resources/safemed-activity-news-digest-november-2019?page=42
[22] https://www.msh.org/resources/safemed-activity-news-digest-november-2019
[23] https://www.msh.org/resources/safemed-activity-news-digest-december-2019?page=42
[24] https://www.msh.org/resources/safemed-activity-news-digest-december-2019
[25] https://www.msh.org/resources/the-added-value-of-combining-ldp-with-clinical-training-on-ppfp-service-delivery?page=42
[26] https://www.msh.org/resources/the-added-value-of-combining-ldp-with-clinical-training-on-ppfp-service-delivery
[27] https://www.msh.org/resources/cameroon-study-research-brief?page=42
[28] https://www.msh.org/resources/cameroon-study-research-brief
[29] https://www.msh.org/resources/designing-and-implementing-a-highly-effective-youth-leadership-program?page=42
[30] https://www.msh.org/resources/designing-and-implementing-a-highly-effective-youth-leadership-program
[31] https://www.msh.org/resources/lmgnmcp-project-final-report?page=42
[32] https://www.msh.org/resources/lmgnmcp-project-final-report
[33] https://www.msh.org/resources/fighting-malaria-with-skilled-leadership?page=42
[34] https://www.msh.org/resources/fighting-malaria-with-skilled-leadership
[35] https://www.msh.org/resources/the-added-value-of-long-term-technical-assistance-to-national-malaria-control-programs?page=42
[36] https://www.msh.org/resources/the-added-value-of-long-term-technical-assistance-to-national-malaria-control-programs
[37] https://www.msh.org/resources/long-term-technical-assistance-advisors?page=42
[38] https://www.msh.org/resources/long-term-technical-assistance-advisors
[39] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf
[40] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=41
[41] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=38
[42] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=39
[43] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=40
[44] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=43
[45] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=44
[46] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=45
[47] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=46
[48] https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-technologies/icium2011/ConferenceMaterials/194-zheng-_a.pdf?page=57